Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2296 to 2310 of 9095 results

  1. Povorcitinib for treating moderate to severe active hidradenitis suppurativa after a TNF-alpha inhibitor [ID6569]

    In development Reference number: GID-TA11743 Expected publication date:  13 May 2027

  2. Denecimig (Mim8) for preventing bleeding episodes in haemophilia A in people of any age [ID6400]

    In development Reference number: GID-TA11509 Expected publication date:  24 February 2027

  3. Decitabine–cedazuridine with venetoclax for untreated acute myeloid leukaemia when intensive induction chemotherapy is unsuitable [ID6601]

    In development Reference number: GID-TA11765 Expected publication date: TBC

  4. Iberdomide with dexamethasone and daratumumab for treating relapsed or refractory multiple myeloma after 1 or 2 lines of treatment [TSID12415]

    Awaiting development Reference number: GID-TA12466 Expected publication date: TBC

  5. Botulinum Toxin injection prior to Abdominal wall reconstruction

    Topic prioritisation

  6. Robotic surgery for paediatric population

    Topic prioritisation

  7. CytoSorb for reducing risk of bleeding during cardiac surgery

    Topic prioritisation

  8. MT658 Quit Genius for Smoking Cessation

    Topic prioritisation

  9. The Insides System chyme reinfusion system (MT682)

    Topic prioritisation

  10. Accuro handheld ultrasound device for locating intervertebral space for administration of spinal anaesthesia

    Topic prioritisation

  11. Remimazolam for general anaesthesia [ID3796]

    Topic prioritisation

  12. Liposomal bupivacaine for treating postoperative pain [ID3799]

    Topic prioritisation

  13. Remimazolam for sedation for people having diagnostic or therapeutic procedures [ID3758]

    Topic prioritisation